Vasamed OTC Stock Executives

VSMD -  USA Stock  

USD 0.001  0.0018  64.29%

Vasamed employes about 10 people. The company is managed by 8 executives with total tenure of roughly 144 years, averaging almost 18.0 years of service per executive having 1.25 employees per reported executive. Evaluation of Vasamed management performance can provide insight into the firm performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Vasamed future performance.
Also, please take a look at World Market Map.

Vasamed Insiders 

  Paulita LaPlante  CEO
CEO and President and Director
  Terry Duesterhoeft  President
Vice President of Sales and Marketing

Vasamed Management Team Effectiveness

Vasamed has return on total asset (ROA) of (74.1) % which means that it has lost $74.1 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (367.0) %, meaning that it created substantial loss on money invested by shareholders. Vasamed management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Vasamed Workforce Comparison

Vasamed is rated below average in number of employees category among related companies. The total workforce of Medical Instruments & Supplies industry is at this time estimated at about 154,053. Vasamed adds roughly 10.0 in number of employees claiming only tiny portion of all equities under Medical Instruments & Supplies industry.

Vasamed Profit Margins

The company has Profit Margin (PM) of (56.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (47.24) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.47.

Vasamed Benchmark Summation

The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Highest value over a specified period line plots max value of Vasamed price series. View also all equity analysis or get more info about highest value over a specified period math operators indicator.

Vasamed Notable Stakeholders

A Vasamed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vasamed often face trade-offs trying to please all of them. Vasamed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vasamed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Paulita LaPlante - CEO and President and DirectorProfile
Terry Duesterhoeft - Vice President of Sales and MarketingProfile
Roberta Dircks - CFO and VP of Fin. and Admin.Profile
Andrew Jay - DirectorProfile
Charles Snead - DirectorProfile
Richard Egen - DirectorProfile
Craig Walker - DirectorProfile
Kent Winger - VP of Operations and VP of Strategic Planning and Product Devel.Profile

About Vasamed Management Performance

The success or failure of an entity such as Vasamed often depends on how effective the management is. Vasamed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vasamed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vasamed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please read more on our stock advisor page.
Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota. Vasamed operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.
The data published in Vasamed's official financial statements usually reflect Vasamed's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Vasamed. For example, before you start analyzing numbers published by Vasamed accountants, it's critical to develop an understanding of what Vasamed's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Vasamed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vasamed's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Vasamed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Vasamed. Please utilize our Beneish M Score to check the likelihood of Vasamed's management to manipulate its earnings.

Vasamed Workforce Analysis

Traditionally, organizations such as Vasamed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vasamed within its industry.

Vasamed Manpower Efficiency

Return on Vasamed Manpower

Revenue Per Employee343 K
Revenue Per Executive428.8 K
Net Loss Per Employee193 K
Net Loss Per Executive241.2 K
Working Capital Per Employee14.3 K
Working Capital Per Executive17.9 K
Also, please take a look at World Market Map. Note that the Vasamed information on this page should be used as a complementary analysis to other Vasamed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Vasamed OTC Stock analysis

When running Vasamed price analysis, check to measure Vasamed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vasamed is operating at the current time. Most of Vasamed's value examination focuses on studying past and present price action to predict the probability of Vasamed's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vasamed's price. Additionally, you may evaluate how the addition of Vasamed to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
CEO Directory
Screen CEOs from public companies around the world
Transaction History
View history of all your transactions and understand their impact on performance
The market value of Vasamed is measured differently than its book value, which is the value of Vasamed that is recorded on the company's balance sheet. Investors also form their own opinion of Vasamed's value that differs from its market value or its book value, called intrinsic value, which is Vasamed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vasamed's market value can be influenced by many factors that don't directly affect Vasamed underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vasamed's value and its price as these two are different measures arrived at by different means. Investors typically determine Vasamed value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vasamed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.